Research article · 14 Apr 2026
Research articlePublished 4 Apr 2022
Possible Role of P-Selectin Adhesion in Long-COVID: A Comparative Analysis of a Long-COVID Case vs. an Asymptomatic Post-COVID Case
1Functional Fluidics, Detroit, Michigan, USA; 2Department of Physiology, School of Medicine, Wayne State University, Detroit, Michigan, USA; 3Wayne Pediatrics, Wayne State University, Detroit, Michigan, USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Background: Long-term outcomes of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are now recognized as an emerging public health challenge-a condition termed Long-COVID. The pathophysiology of Long-COVID remains to be established. Functional P-selectin activity, implicated in COVID-19 sequelae, was measured between two convalescent COVID-19 subjects, one with (Long-COVID subject) and another without Long-COVID symptoms. Methods: Flow adhesion of whole blood or isolated white blood cells to P-selectin (FA-WB-Psel and FA-WBC-Psel) was measured using a standardized microfluidics clinical assay; impedance aggregometry with a collagen agonist was measured using model 590 Chrono-Log impedance aggregometer; standard laboratory assays were performed to evaluate changes in blood chemistries. Results: For both subjects, hemoglobin, WBC, platelet counts, electrolytes and ferritin were within normal reference ranges, with FA-WB-Psel significantly elevated compared to healthy controls (p< 0.01). In vitro treatment of whole blood samples with crizanlizumab (anti-p-selectin monoclonal antibody) within the clinical dose range (10 μg/ml) inhibited FA-WB-Psel only in samples from asymptomatic Post-COVID subject, with the Long-COVID subject sample requiring close to 5-fold elevated dose to achieve a response. Pronounced inhibition of P-selectin adhesion of isolated leukocytes was observed for both subjects in autologous platelet-poor plasma and buffer. Impedance aggregometry showed greater baseline platelet aggregation to collagen in the Long-COVID sample, although both samples responded similarly to aspirin-induced platelet inhibition. Conclusion: Presented results suggest that elevated platelet activation in Long-COVID subject may be associated with increased P-selectin activity. The results are discussed in terms of possible use of P-selectin inhibition therapies in treating Long-COVID.
Subjects
Infectious DiseasesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Infectious Diseases & Therapy.
Research article · 5 May 2025
The Ultimate Cure for the COVID Syndemic
Mini review · 29 Apr 2025
COVID-19 Systematic Mini-Review as of April 2025
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Infectious Diseases & Therapy
- SubjectInfectious Diseases
- BylineArticles whose byline prints “Michael Tarasev”
- BylineArticles whose byline prints “Sabrina Mota”
- BylineArticles whose byline prints “Xiufeng Gao”
- BylineArticles whose byline prints “Marta Ferranti”
- BylineArticles whose byline prints “Aliya U. Zaidi”
- BylineArticles whose byline prints “Bryan Hannan”
- BylineArticles whose byline prints “Patrick Hines”